Advertisement

Arterielle Verschlusskrankheit (AVK)

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literaturverzeichnis

  1. 26.
    Antiplatelet Trialists‘ Collaboration (1994) Collaborative overview of randomised trials of antiplatelet therapy — I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J 308:81–106 (erratum published in Br Med J 308:1540)Google Scholar
  2. 51.
    Balsano F, Cocceri S, Libretti A et al (1989) Ticlopidine in the treatment of intermittend claudication: a 21-month double-blind trial. J Lab Clin Med 114:84–91PubMedGoogle Scholar
  3. 56.
    Basta L, Plunkitt K, Shashy R et al (1998) Cardiopulmonary resuscitation in the elderly: defining the limits of appropriateness. Am J Geriatr Cardiol 7:46–55PubMedGoogle Scholar
  4. 71.
    Bernstein EF, Frontek A (1982) Current status of noninvasive tests in the diagnosis of peripheral arterial disease. Surg Clin North Am 62:473–487PubMedGoogle Scholar
  5. 72.
    Bergqvist D, Almgren B, Dickinson JP (1995) Reduction of requirement for leg vascular surgery during long-term treatment of claudicant patients with ticlopidine: results from the Swedish Ticlopidine Multicentre Study (STIMS). Eur J Vasc Endovasc Surg 10:69–76CrossRefPubMedGoogle Scholar
  6. 76.
    Blankenhorn DH, Azen SP, Crawford DW et al (1991) Effects of colestipolniacin therapy on human femoral atherosclerosis. Circulation 83:438–447PubMedGoogle Scholar
  7. 77.
    Blann AD, Gurney D, Hughes E et al (2001) Influence of pravastatin on lipoproteins and on endothelial platelet, and inflammatory markers in subjects with peripheral artery disease. Am J Cardiol 88:89–92CrossRefGoogle Scholar
  8. 91.
    Brearley S, Shearman CP, Simms MH (1992) Peripheral pulse palpation: an unreliable physical sign. Ann R Coll Surg Engl 74:169–171PubMedGoogle Scholar
  9. 101.
    Buchwald H, Bourdages HR, Campos CT et al (1996) Impact of cholesterol reduction on peripheral arterial disease in the Program on the Surgical Controll of the Hyperlipidemias (POSCH) Surgery 120:672–679PubMedGoogle Scholar
  10. 155.
    Criqui MH, Fronek A, Barrett-Conner E et al (1985) The prevalence of peripheral arterial disease in a defined population. Circulation 71:510–515PubMedGoogle Scholar
  11. 156.
    Criqui MH, Fronek A, Barrett-Conner E et al (1985) The sensitivity, specificity, and predictive value of traditional clinical evaluation of peripheral arterial disease: results from noninvasive testing in a defined population. Circulation 71:516–522PubMedGoogle Scholar
  12. 157.
    Criqui MH, Langer RD, Fronek A et al (1992) Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 326:381–386PubMedGoogle Scholar
  13. 205.
    Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (ATP III). JAMA 285:2486–2497Google Scholar
  14. 210.
    Farkouh M, Oddone EZ, Simel DL, for the International Cooperative Group for Clinical Examination Improving the clinical examination for a low ankle-brachial index. Int J Angiol (in press)Google Scholar
  15. 230.
    Fowkes FG, Housley E, Cawood EH et al (1991) Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral disease in the general population. Int J Epidemiol 20:384–392PubMedGoogle Scholar
  16. 248.
    Gardner AW, Poehlman ET (1995) Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis. JAMA 274:975–980CrossRefPubMedGoogle Scholar
  17. 255.
    Girolami B, Bernardi E, Prins MH et al (1999) Treatment of intermittend claudication with physical training, smoking cessation, pentoxifylline, or nafronyl: a meta-analysis. Arch Intern Med 159:337–345CrossRefPubMedGoogle Scholar
  18. 258.
    Goldhaber SZ, Manson JE, Stampfer MJ et al (1992) Low-dose aspirin and subsequent peripheral arterial surgery in the Physicians‘ Health Study. Lancet 340:143–145CrossRefPubMedGoogle Scholar
  19. 262.
    Gordis L (1990) Evaluating the evidence for the effectiveness of prevention. J Gen Intern Med 5(suppl 5):S14–S16PubMedGoogle Scholar
  20. 295.
    Hiatt WR (2001) Medical treatment of peripheral arterial disease and claudication. N Engl J Med 344:1608–1621CrossRefPubMedGoogle Scholar
  21. 298.
    Hirsch AT, Criqui MH, Treat-Jacobson D et al (2001) The PARTNERS program: a national survey of peripheral arterial disease detection, awareness, and treatment. JAMA 286:1317–1324CrossRefPubMedGoogle Scholar
  22. 307.
    Howell MA, Colgan MP, Seeger RW et al (1989) Relationship of severity of lower limb peripheral vascular disease to mortality and morbidity: a six-year follow-up study. J Vasc Surg 9:691–697CrossRefPubMedGoogle Scholar
  23. 308.
    Hsia J, Simon JA, Lin F et al (2000) Peripheral arterial disease in a randomized trial of estrogen with progestin in women with coronary heart disease: the Heart and Estrogen/Progestin Replacement Study. Circulation 102:2228–2232PubMedGoogle Scholar
  24. 327.
    Janzon L, Bergqvist D, Boberg J et al (1990) Prevention of myocardial infarction and stroke in patients with intermittent claudication: effects of ticlopidine: results from STIMS, the Swedisch Ticlopidine Multicenter Study (erratum published in J Intern Med 228:659). J Inter Med 227:301–308Google Scholar
  25. 417.
    Leng GC, Price JF, Jepson RG (2000) Lipid-lowering for lower limb atherosclerosis. Cochrane Database Syst Rev 2:CD000123Google Scholar
  26. 427.
    Lewis B (1985) Randomised controlled trial of the treatment of hyperlipidaemia on progression of atherosclerosis. Acta Med Scand Suppl 701:53–57PubMedGoogle Scholar
  27. 428.
    Lewis SJ, Moye LA, Sacks FM et al (1998) Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Ann Intern Med 129:681–689PubMedGoogle Scholar
  28. 466.
    McDermott McGrae M (2002) Peripheral arterial disease: epidemiology and drug therapy. Am Geriatr Cardiol 11:258–266Google Scholar
  29. 467.
    McDermott MM, Feinglass J, Slavensky R et al (1994) The ankle brachial index as a predictor of survival in patients with peripheral vascular disease. J Gen Intern Med 9:445–449PubMedGoogle Scholar
  30. 468.
    McDermott MM, Greenland P, Liu K et al (2001) Leg symptoms commonly reported by men and women with lower extremity peripheral arterial disease: associated clinical characteristics and functional impairment. JAMA 286:1599–1606CrossRefPubMedGoogle Scholar
  31. 469.
    McDermott MM, Kerwin DR, Liu K et al (2001) Prevalence and significance of unrecognized lower extremity peripheral arterial disease in general medicine practice. J Gen Inter Med 16:384–390CrossRefGoogle Scholar
  32. 471.
    McKenna M, Wolfson S, Kuller L (1991) The ratio of ankle and arm arterial pressure as an independent predictor of mortality. Atherosclerosis 87:119–128CrossRefPubMedGoogle Scholar
  33. 476.
    Meijer WT, Grobbee DE, Hunik MG et al (2000) Determinants of peripheral arterial disease in the elderly: the Rotterdam Study. Arch Intern Med 160:2934–2938CrossRefPubMedGoogle Scholar
  34. 478.
    Meyers KA, Scott DF, Devine TJ et al (1987) Palpation of the femoral and popliteal pulses: a study of the accuracy as assessed by agreement between multiple observers. Eur J Vasc Surg 1:245–249CrossRefPubMedGoogle Scholar
  35. 480.
    Miettinen TA, Pyorala K, Olsson AG et al (1997) Cholesterol lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian Simvastatin Survival Study (4S). Circulation 96:4211–4218PubMedGoogle Scholar
  36. 485.
    Moffat C, O’Hare L (1995) Ankle pulses are not sufficient to detect impaired arterial circulation in patients with leg ulcers. J Wound Care 4:134–138PubMedGoogle Scholar
  37. 516.
    Newman AB, Sicovick DS, Manolio TA et al (1993) Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Circulation 88:837–845PubMedGoogle Scholar
  38. 517.
    Newman AB, Sutton-Tyrrell K, Vogt MT et al (1993) Morbidity and mortality in hypertensive adults with a low ankle/arm blood pressure index. JAMA270:487–489CrossRefPubMedGoogle Scholar
  39. 530.
    Olin JW (1998) The clinical evaluation and office bases detection of peripheral arterial disease. In: Hirsch AT, Olin FW (eds) An Office-Based Approach to the Diagnosis and Treatment of Peripheral Arterial Disease, I: the epidemiology and practical detection of peripheral arterial disease. American Journal of Medicine Continuing Education Series. Excerpta Medica, Belle Meade, NJ, pp 10–17Google Scholar
  40. 550.
    Pedersen TR, Kjekshus J, Pyorala K et al (1998) Effect of simvastatin on ischemic signs and symptoms in the Scandinavian Simvastatin Survival Study (4S). Am J Cardiol 81:333–335CrossRefPubMedGoogle Scholar
  41. 573.
    Radack K, Deck C (1991) Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease: a meta-analysis of randomized controlled trials. Arch Intern Med 151: 1769–1776CrossRefPubMedGoogle Scholar
  42. 600.
    Sacks FM, Pfeffer MA, Moye LA et al (1996) The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrents Events Trial. N Engl J Med 335:1001–1009CrossRefPubMedGoogle Scholar
  43. 614.
    Scandinavian Simvastatin Survival Study Group (1994) Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344:1383–1389Google Scholar
  44. 709.
    The Heart Outcomes Prevention Evaluation Study Investigators (2000) Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 342:145–153Google Scholar
  45. 723.
    Timaran CH, Steven SL, Grandas OH et al (2000) Influence of hormone replacement therapy on graft patency after femoropopliteal bypass grafting. J Vasc Surg 32:506–518CrossRefPubMedGoogle Scholar
  46. 752.
    Vogt MT, Cauley JA, Kuller LH et al (1993) Prevalence and correlates of lower extremity arterial disease in elderly women. Am J Epidemiol 137:559–568PubMedGoogle Scholar
  47. 753.
    Vogt MT, Cauley JA, Newman AB et al (1993) Decreased ankle/arm blood pressure index and mortality in elderly women. JAMA 270:465–469CrossRefPubMedGoogle Scholar
  48. 773.
    Weitz JI, Byrine J, Clagett P et al (1996) Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation94:3026–3049PubMedGoogle Scholar
  49. 784.
    Winsor T (1950) Influence of arterial disease on the systolic blood pressure gradients of the extremity. Am J Med Sci 220:117–126PubMedGoogle Scholar
  50. 795.
    Yao JS (1973) New techniques of objective arterial evaluation. Arch Surg 106:600–604PubMedGoogle Scholar

Copyright information

© Steinkopff Verlag Darmstadt 2005

Personalised recommendations